R
Rimda Wanchoo
Researcher at Hofstra University
Publications - 61
Citations - 4746
Rimda Wanchoo is an academic researcher from Hofstra University. The author has contributed to research in topics: Acute kidney injury & Kidney disease. The author has an hindex of 16, co-authored 54 publications receiving 1011 citations. Previous affiliations of Rimda Wanchoo include Long Island Jewish Medical Center.
Papers
More filters
Journal ArticleDOI
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.
Rimda Wanchoo,Sabine Karam,Nupur N. Uppal,Valerie S. Barta,Gilbert Deray,Craig Devoe,Vincent Launay-Vacher,Kenar D. Jhaveri +7 more
TL;DR: Although initially thought to be rare, the incidence rates of renal toxicities might be higher as identified by recent studies, Steroids appear to be effective in treating the immune-related adverse effects noted with these agents.
Journal ArticleDOI
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
Purva Sharma,Nupur N. Uppal,Rimda Wanchoo,Hitesh H. Shah,Yihe Yang,Rushang Parikh,Yuriy Khanin,Varun Madireddy,Christopher P. Larsen,Kenar D. Jhaveri,Vanesa Bijol +10 more
TL;DR: The most common finding in kidney biopsy samples from ten hospitalized patients with AKI and COVID-19 was acute tubular necrosis, and there was no evidence of SARS-CoV-2 in the biopsied kidney tissue.
Journal ArticleDOI
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.
Jia H. Ng,Jamie S. Hirsch,Jamie S. Hirsch,Rimda Wanchoo,Mala Sachdeva,Vipulbhai Sakhiya,Susana Hong,Kenar D. Jhaveri,Steven Fishbane,Mersema Abate,Hugo Paz Andrade,Richard Barnett,Alessandro G. Bellucci,Madhu Bhaskaran,Antonio G. Corona,Bessy Suyin Flores Chang,Mark Finger,Michael Gitman,Candice Halinski,Shamir Hasan,Azzour D. Hazzan,Yuriy Khanin,Aireen Kuan,Varun Madireddy,Deepa Malieckal,Abdulrahman Muzib,Gayatri Nair,Jia Hwei Ng,Rushang Parikh,Daniel W. Ross,Richard Schwarz,Hitesh H. Shah,Purva Sharma,Pravin C. Singhal,Nupur N. Uppal,Vinay Nair +35 more
TL;DR: Among patients hospitalized with COVID-19, those with end-stage kidney disease had a higher rate of in-hospital death compared to those without ESKD, and Black race was associated with a lower risk of death.
Journal ArticleDOI
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
Jia H. Ng,Jamie S. Hirsch,Jamie S. Hirsch,Azzour D. Hazzan,Rimda Wanchoo,Hitesh H. Shah,Deepa A. Malieckal,Daniel W. Ross,Purva Sharma,Vipulbhai Sakhiya,Steven Fishbane,Kenar D. Jhaveri,Mersema Abate,Hugo Paz Andrade,Richard Barnett,Alessandro G. Bellucci,Madhu Bhaskaran,Antonio G. Corona,Bessy Suyin Flores Chang,Mark Finger,Michael Gitman,Candice Halinski,Shamir Hasan,Azzour D. Hazzan,Susana Hong,Yuriy Khanin,Aireen Kuan,Varun Madireddy,Deepa Malieckal,Abdulrahman Muzib,Gayatri Nair,Vinay Nair,Jia Hwei Ng,Rushang Parikh,Mala Sachdeva,Richard Schwarz,Pravin C. Singhal,Nupur N. Uppal +37 more
TL;DR: The goal of this study was to investigate the survival and kidney outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) and acute kidney injury (AKI) and to observe greater risks for in-hospital death for patients with AKI 1-3 and AKI 3D.